119th (2025–2027)
H.R. 5630
H.R. 5630 requires states to provide more detailed information when applying for federal substance abuse prevention and treatment block grants. Specifically, states would need to report on the types of medications they use for medication-assisted treatment (like methadone or buprenorphine), their programs to prevent misuse of these medications, data on any documented misuse incidents, and their drug screening protocols. The bill affects state health departments and substance abuse treatment programs that receive these federal grants. No new funding is created by this bill; it simply adds reporting requirements to existing grant applications. The legislation aims to give the federal government better visibility into how states are managing medication-assisted treatment programs and addressing potential misuse of these drugs.